Creating New Enabling Materials for Analysis, Diagnosis, and Therapy

Breast Cancer Cells micrographNanoquantum is a photonic materials solutions company actively engaged in the development of new photo-chemical compounds and related photonic technologies.

Our business is developing, manufacturing, and selling novel photoluminescent labels, photosensitizers, and related technologies. We also license the use of our enabling materials and technologies to organizations that will create and qualify new analytical methods, diagnostics, and therapeutics using our products and technologies.

Our new non-toxic dye compounds provide high stability and higher efficiency near-infrared photoluminescent brightness (extinction * quantum yield) than any other small-molecule biological labels currently in the market.

Several of our high-brightness near-IR photoluminescent materials can also provide additional functionality as high X-ray contrast agents and as photoacoustic imaging reporters

We are undertaking these efforts with the goal of opening new doors with customers and licensees to create new analytical capabilities, as well as diagnostic and therapeutic solutions for many cancers, antibiotic resistant pathogens, as visualization aids in surgery or radiation therapy, and for other applications our core technology can address.


High brightness and light-sensitive, near-infrared photoluminescent dyes for biological labeling.

Products For Licensing (Contact us with inquiries and to purchase materials at:

  • Ultra-high brightness, near-infrared photoluminescent dyes for biological labeling with extinction coefficients from 200K to over 750K M-1cm-1

  • Near-IR photodynamic compounds with extremely high photon capture probabilities for activation deep in tissue

  • High-intensity, low-cost, large area, near-IR light sources and exposure systems

  • Photonic feedback sensors and imaging systems for activation, monitoring, and analytical testing



Recent Publications Regarding Nanoquantum Sciences's Patented Materials Technology

January 2017:

Chemical Communications Journal - DOI: 10.1039/C6CC09624G

Iodinated Cyanine Dyes: A New Class of Sensitisers for use in NIR Activated Photodynamic Therapy (PDT)†

Jordan Atchison,a  Sukanta Kamila,a  Heather Nesbitt,a  Kieran A. Logan,a  Dean M Nicholas,a  Colin Fowley,a  James Davis,b  Bridgeen Callan,a  Anthony P McHalea  and  John F Callan*a 

* Corresponding authors

a Biomedical Sciences Research Institute, University of Ulster, Coleraine, UK

b Engineering Research Institute, University of Ulster, Coleraine, UK

Electronic Supplementary Material (ESI) for ChemComm.
This journal is © The Royal Society of Chemistry 2017

Subject: Panceatic Cancer


June 2017 :

ACS Appl Mater Interfaces 2017 Jun 31;9(23):19601-19611. Epub 2017 May 31.

Optical Characteristics and Tumor Imaging Capabilities of Near Infrared Organic Chromophores
(ICG and BrCy106) in Non- and Nano-Encapsulated Formulations,

Yadir Guerrero,† Sheela P. Singh,§ Turong Mai,†
Ravoori K. Murali,§ Leela K. Tanikella,†Ata Zahedi,†Vikas Kundra,§ and Bahman Anvari†*

† Department of Bioengineering, University of California, Riverside, CA 92521, United States

§Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center,
Houston, TX 77030, United States

Subject: Ovarian Cancer